KraneShares MSCI All China Health Care Index ETF (KURE)
14.74
+0.00 (0.00%)
NYSE · Last Trade: Apr 20th, 4:44 PM EDT
Detailed Quote
Previous Close | 14.74 |
---|---|
Open | 14.64 |
Day's Range | 14.46 - 14.81 |
52 Week Range | 12.91 - 20.51 |
Volume | 6,312 |
Market Cap | 810.70K |
Dividend & Yield | N/A (N/A) |
1 Month Average Volume | 117,895 |
Chart
News & Press Releases
These ETFs beat the S&P 500 in April 2025’s turbulent market. Learn how TOLZ, VIXY, and KURE can help stabilize your investment strategy.
Via MarketBeat · April 15, 2025
Even as Donald Trump paused the reciprocal tariffs for 90 days, he later confirmed that pharmaceutical companies would face tariffs.
Via Benzinga · April 11, 2025

China's NPC meeting has sparked optimism in the market, with Chinese stocks and bonds rallying. Investors are hopeful for growth targets but remain skeptical.
Via Benzinga · March 7, 2025
China Stocks Look Set For A Rebound, Morgan Stanley Quant Strategists Saybenzinga.com
Investors in mainland China are rapidly unwinding their stock-index hedges, in an indication that a possible end to Chengdu’s lockdown and policies to stabilize the yuan will lead to a near-term market rally, reported
Via Benzinga · September 13, 2022